These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 33316405

  • 1. Molecular docking and synthesis of caffeic acid analogous and its anti-inflammatory, analgesic and ulcerogenic studies.
    Al-Ostoot FH, Zabiulla, Grisha S, Mohammed YHE, Vivek HK, Ara Khanum S.
    Bioorg Med Chem Lett; 2021 Feb 01; 33():127743. PubMed ID: 33316405
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents.
    Banerjee AG, Das N, Shengule SA, Srivastava RS, Shrivastava SK.
    Eur J Med Chem; 2015 Aug 28; 101():81-95. PubMed ID: 26117820
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and molecular docking of benzophenone conjugated with oxadiazole sulphur bridge pyrazole pharmacophores as anti inflammatory and analgesic agents.
    Zabiulla, Gulnaz AR, Mohammed YHE, Khanum SA.
    Bioorg Chem; 2019 Nov 28; 92():103220. PubMed ID: 31493708
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of new ibuprofen hybrid conjugates as potential anti-inflammatory and analgesic agents.
    Panda SS, Girgis AS, Honkanadavar HH, George RF, Srour AM.
    Future Med Chem; 2020 Aug 28; 12(15):1369-1386. PubMed ID: 32689823
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile.
    Abdelazeem AH, El-Saadi MT, Safi El-Din AG, Omar HA, El-Moghazy SM.
    Bioorg Med Chem; 2017 Jan 15; 25(2):665-676. PubMed ID: 27916468
    [Abstract] [Full Text] [Related]

  • 6. Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory activity.
    Halim PA, Georgey HH, George MY, El Kerdawy AM, Said MF.
    Bioorg Chem; 2021 Oct 15; 115():105253. PubMed ID: 34390973
    [Abstract] [Full Text] [Related]

  • 7. 1,4-Dihydroquinazolin-3(2H)-yl benzamide derivatives as anti-inflammatory and analgesic agents with an improved gastric profile: Design, synthesis, COX-1/2 inhibitory activity and molecular docking study.
    Sakr A, Kothayer H, Ibrahim SM, Baraka MM, Rezq S.
    Bioorg Chem; 2019 Mar 15; 84():76-86. PubMed ID: 30481648
    [Abstract] [Full Text] [Related]

  • 8. Novel 1,3,4-oxadiazole/oxime hybrids: Synthesis, docking studies and investigation of anti-inflammatory, ulcerogenic liability and analgesic activities.
    Abd-Ellah HS, Abdel-Aziz M, Shoman ME, Beshr EA, Kaoud TS, Ahmed AF.
    Bioorg Chem; 2016 Dec 15; 69():48-63. PubMed ID: 27669120
    [Abstract] [Full Text] [Related]

  • 9. New 1,2-diaryl-4-substituted-benzylidene-5-4H-imidazolone derivatives: Design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents.
    Abdellatif KRA, Fadaly WAA.
    Bioorg Chem; 2017 Jun 15; 72():123-129. PubMed ID: 28411407
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
    Khalil NA, Ahmed EM, Mohamed KO, Nissan YM, Zaitone SA.
    Bioorg Med Chem; 2014 Apr 01; 22(7):2080-9. PubMed ID: 24631365
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies.
    Abdel-Aziz AA, El-Azab AS, Abou-Zeid LA, ElTahir KE, Abdel-Aziz NI, Ayyad RR, Al-Obaid AM.
    Eur J Med Chem; 2016 Jun 10; 115():121-31. PubMed ID: 26999325
    [Abstract] [Full Text] [Related]

  • 12. Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations.
    Mohammed ER, Abd-El-Fatah AH, Mohamed AR, Mahrouse MA, Mohammad MA.
    Bioorg Chem; 2024 Jun 10; 147():107372. PubMed ID: 38653152
    [Abstract] [Full Text] [Related]

  • 13. Novel sulindac derivatives: synthesis, characterisation, evaluation of antioxidant, analgesic, anti-inflammatory, ulcerogenic and COX-2 inhibition activity.
    Bhat MA, Al-Omar MA, Alsaif NA, Almehizia AA, Naglah AM, Razak S, Khan AA, Ashraf NM.
    J Enzyme Inhib Med Chem; 2020 Dec 10; 35(1):921-934. PubMed ID: 32238055
    [Abstract] [Full Text] [Related]

  • 14. New indomethacin analogs as selective COX-2 inhibitors: Synthesis, COX-1/2 inhibitory activity, anti-inflammatory, ulcerogenicity, histopathological, and docking studies.
    Abdellatif KRA, Abdelall EKA, Elshemy HAH, El-Nahass ES, Abdel-Fattah MM, Abdelgawad YYM.
    Arch Pharm (Weinheim); 2021 Apr 10; 354(4):e2000328. PubMed ID: 33314237
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, molecular docking and biological evaluation of some newer 2-substituted-4-(benzo[d][1,3]dioxol-5-yl)-6-phenylpyridazin-3(2H)-ones as potential anti-inflammatory and analgesic agents.
    Singh J, Saini V, Kumar A, Bansal R.
    Bioorg Chem; 2017 Apr 10; 71():201-210. PubMed ID: 28236449
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis, potential anti-inflammatory and analgesic activities study of (S)-N-substituted-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxamides.
    Guan LP, Xia YN, Jin QH, Liu BY, Wang SH.
    Bioorg Med Chem Lett; 2017 Aug 01; 27(15):3378-3381. PubMed ID: 28610982
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Amide derivatives of [5-chloro-6-(2-chloro/fluorobenzoyl)-2-benzoxazolinone-3-yl]acetic acids as potential analgesic and anti-inflammatory compounds.
    Banoglu E, Okçelik B, Kupeli E, Unlü S, Yeşilada E, Amat M, Caturla JF, Sahin MF.
    Arch Pharm (Weinheim); 2003 Jul 01; 336(4-5):251-7. PubMed ID: 12916060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.